A Study to Evaluate Serplulimab in Combination With Docetaxel +S-1 VS. Docetaxel +S-1 as Adjuvant Treatment Therapy in Stage IIIc Gastric Cancer

Clinical trial NCT05769725 · UNKNOWN

Trial details

NCT number: NCT05769725
Sponsor: RenJi Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Serplulimab,Gastric Cancer, Adjuvant Therapy

Start date: 2023-03-01
Primary completion: 2025-03-31
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.